Glucose Laboratoire Aguettant

Glucose Laboratoire Aguettant is a sterile intravenous solution that contains glucose monohydrate as its sole active ingredient. Formulated as a sterile solution for injection, it is supplied in a pharmaceutical strength suitable for intravenous administration. The product is manufactured in the European Union and is available by prescription (Rx) for use in clinical settings where rapid glucose delivery is required under controlled conditions and proper handling.

Glucose Laboratoire Aguettant is used in several clinical situations where rapid provision of carbohydrate energy or fluid balance is needed.

- Treatment of acute hypoglycemia when oral glucose is not feasible. - As part of fluid replacement therapy in patients requiring isotonic solutions. - Component of parenteral nutrition regimens to supply calories. - Support during surgical procedures to maintain blood glucose levels. - Management of electrolyte imbalances when combined with appropriate salts.

When administered intravenously, Glucose Laboratoire Aguettant may be associated with a range of observed effects, most of which are related to the infusion of a carbohydrate solution and the accompanying osmotic load.

Common: - Transient increase in blood glucose concentration. - Mild hyperosmolarity leading to temporary thirst. - Local irritation at the injection site. - Nausea or mild gastrointestinal discomfort. - Temporary rise in serum insulin levels.

Serious: - Severe hyperglycemia, especially in patients with diabetes mellitus. - Fluid overload resulting in pulmonary edema. - Electrolyte disturbances such as hyponatremia.

Clinicians should observe specific precautions when prescribing or administering Glucose Laboratoire Aguettant to minimize risks and ensure patient safety.

- Verify blood glucose levels before and during infusion. - Adjust infusion rate in patients with impaired renal or cardiac function. - Use aseptic technique to prevent contamination of the sterile solution. - Monitor fluid balance to avoid overload, especially in elderly or critically ill patients. - Consider contraindications in individuals with known hypersensitivity to glucose solutions. - Avoid rapid bolus administration unless clinically indicated. - Store according to manufacturer guidelines, protecting from light and extreme temperatures.

Glucose Laboratoire Aguettant can interact with other medications or clinical conditions, requiring careful assessment to avoid adverse outcomes.

Avoid: - Concurrent high‑dose insulin therapy without glucose monitoring. - Co‑administration with hypertonic saline solutions that may exacerbate hyperosmolar states.

Use with caution: - Diabetic patients receiving oral hypoglycemic agents; monitor glucose closely. - Patients on diuretics or cardiac drugs, as fluid shifts may affect drug distribution. - Use with caution in renal impairment where glucose clearance is reduced. - Concurrent administration with potassium‑containing solutions; monitor electrolyte levels.